GPX4 predicts poor prognosis and regulates tumor proliferation and senescence in colorectal adenocarcinoma
Oncology Research · 2025
DOI: 10.32604/or.2025.063395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Y U Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Hospital of Yanbian University, Yanji, 133002, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenocarcinoma, Cellular Senescence, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Colorectal adenocarcinoma (COAD) is one of the most common gastrointestinal malignancies. There is a pressing need to recognize reliable biomarkers that can improve diagnostic accuracy, predict prognosis, and serve as effective molecular targets. Glutathione peroxidase 4 (GPX4) is an important antioxidant protein. Evidence demonstrates that abnormal expression of GPX4 is related to cancer initiation and progression. However, the role of GPX4 in COAD remains unclear.
Methods
We employed bioinformatics analysis and conducted subsequent validation of biological processes, including cell counting kit-8 assay (CCK-8), colony formation assay, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), 5-ethynyl-2'-deoxyuridine assay (EdU), western blot, immunohistochemistry, senescence associated β-galactosidase (SA-β-gal) staining and immunofluorescence to explore the expression status, prognostic value and biological function of GPX4 in COAD.
Results
Our data revealed that GPX4 mRNA expression was upregulated in COAD tissues and could predict the prognosis in patients with COAD. High GPX4 expression was associated with increased infiltration of malignant cells. We also performed a series of cell experiments confirming that GPX4 knockdown inhibited proliferation and induced cellular senescence, as determined by using CCK-8, colony formation, and EdU assay. In addition, SA-β-gal staining and senescence-associated secretory phenotype (SASP) components, such as P21 and Interleukin-6 (IL-6), were increased in GPX4 knockdown cells, while Lamin B1 was decreased. Moreover, we predicted that high expression of GPX4 was related to low immune cell infiltration.
Conclusion
This study demonstrates that GPX4 is a potential prognostic biomarker and target gene for COAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Affiliated Hospital of Yanbian University, Yanji, 133002, China.
- Key Laboratory of Pathobiology (Yanbian University), State Ethnic Affairs Commission, Yanji, 133002, China.
Zitieren
APA
Zhang, Y. U., Wang, Q., Han, Y., Piao, J., & Jin, X. (2025). GPX4 predicts poor prognosis and regulates tumor proliferation and senescence in colorectal adenocarcinoma. Oncology Research. https://doi.org/10.32604/or.2025.063395
Vancouver
Zhang YU, Wang Q, Han Y, Piao J, Jin X. GPX4 predicts poor prognosis and regulates tumor proliferation and senescence in colorectal adenocarcinoma. Oncology Research. 2025. doi:10.32604/or.2025.063395
BibTeX
@article{Zhang2025,
author = {Zhang, Y U and Wang, Qingkun and Han, Yue and Piao, Junjie and Jin, Xiuying},
title = {GPX4 predicts poor prognosis and regulates tumor proliferation and senescence in colorectal adenocarcinoma},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2025.063395}
}
EUVIMED